AAA September 2015 – Page 12

Proteostasis gets moving with $37m

US-based drug developer Proteostasis Therapeutics raised a $37m series B round on Tuesday featuring pharmaceutical firms Sanofi and Novartis, as well as Elan Science One, a subsidiary of healthcare company Perrigo. The round, secured in the form of mezzanine capital, was led by Cormorant Asset Management. Fidelity Biosciences, a venture capital arm of financial services… Continue reading Proteostasis gets moving with $37m